Primary Job Title Founder and CEO Primary Organization Rezolute
Gender Male
LinkedIn View on LinkedIn
Nevan Charles Elam is the Chief Executive Officer and Founder of Rezolute. Nevan Charles Elam, JD, has a rich background in management/operations, consulting, finance, and corporate law and has worked extensively in emerging markets.
Prior to forming the Konus Advisory Group, He was CEO of AeroSurgical Limited, a European medical device
company, and former SVP, Head of the Pulmonary Business Unit at Nektar Therapeutics (Nasdaq: NKTR), which he sold to Novartis in 2008.
Prior to his role at Nektar he was CFO and co-founder of E2open, (NASDAQ: EOPN), an IT platform company serving the electronics and healthcare industries where, in addition to managing finance and corporate and business development, Mr. Elam established operations in five locations in Asia including Singapore, Kuala Lumpur, Taipei, Tokyo, and Seoul.
Mr. Elam is currently CEO of AntriaBio (OTC: ANTB) and a board member of that company as well as Savara Pharmaceuticals and Aerogen Limited. Earlier in his career, Mr. Elam was a corporate partner at Wilson Sonsini Goodrich & Rosati, a leading global law firm advising healthcare organizations.
Mr. Elam has a rich and diverse background in the emerging markets, including Asia, Africa, India, the Middle East, and South America, where he has managed operations, invested and advised clients on a range of transactions from financings and corporate partnerships to acquisitions.
Mr. Elam received his JD from Harvard Law School and his BA from Howard University.
